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1 Department of Biological Sciences, Old Dominion University, Norfolk, VA, United States, 2 Center for Molecular Medicine,
Old Dominion University, Norfolk, VA, United States
Tetraspanin family of proteins participates in numerous fundamental signaling pathways
involved in viral transmission, virus-specific immunity, and virus-mediated vesicular
trafficking. Studies in the identification of novel therapeutic candidates and strategies to
target West Nile virus, dengue and Zika viruses are highly warranted due to the failure in
development of vaccines. Recent evidences have shown that the widely distributed
tetraspanin proteins may provide a platform for the development of novel therapeutic
approaches. In this review, we discuss the diversified and important functions of
tetraspanins in exosome/extracellular vesicle biology, virus-host interactions, virus-
mediated vesicular trafficking, modulation of immune mechanism(s), and their possible
role(s) in host antiviral defense mechanism(s) through interactions with noncoding RNAs.
We also highlight the role of tetraspanins in the development of novel therapeutics to
target arthropod-borne flaviviral diseases.
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INTRODUCTION
Membrane receptor proteins actively participate in order to control specific cellular functions due to
their unique architecture, composition, stability and their ability to regulate the signaling from
inside out (1, 2). Tetraspanin proteins containing transmembrane domains are responsible for
characteristic functions in membrane compartmentalization and in biological processes including
adhesion, viral infection/transmission, differentiation, cell signaling, and motility (2). Several studies
have shown that tetraspanins play a significant role in modulation and in trafficking of other host
membrane proteins (3–5). Tetraspanins have also been shown to play key role(s) in flaviviruses
entry and exit process (2), transmission from arthropod to mammalian cells (6), and in cell-to-cell
spreading (7). Arthropod-borne flaviviruses are emerging and re-emerging pathogens responsible
for substantial morbidity and mortality with clinical conditions, such as congenital malformations,
neurological complications, brain encephalitis, severe hemorrhagic syndromes and multiple organ
failures (8, 9). Among viruses that belong to the family of Flaviviridae, the Flavivirus genus includes
more than seventy small, positive-sense single-stranded RNA viruses transmitted by vectors, such as
ticks and mosquitoes (10, 11). This genus comprises of broadly distributed and important human
pathogens including dengue virus (DENV), yellow fever virus (YFV), West Nile virus (WNV),
Japanese encephalitis virus (JEV), Zika virus (ZIKV), tick-borne: encephalitis virus (TBEV), Langat
virus (LGTV), Powassan virus (POWV) and Murray Valley encephalitis virus (MVE) (8, 9, 12).
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Flaviviruses are assembled using a dense and organized array of
three structural proteins (Envelope, E, Membrane, prM, and
capsid, C), the viral genomic RNA and a host lipid envelope (13).
Flaviviruses entry into a target cell is dependent on the
glycoprotein E binding to a cellular receptor(s) (13). It has
been shown that flaviviruses use a wide range of cell surface
receptors for entry into host cells, that includes C-type Lectin,
AXL and MER, TYRO3 and aVb3 integrins (14). Flaviviruses
enter host cells via clathrin-mediated endocytosis. During this
process, a series of organizational and conformational changes in
viral E glycoprotein occurs, that are triggered by low pH for
consequent viral membrane fusion, and thus resulting in the
release of nucleocapsid into the host cell cytoplasm (11, 13).
Recent research highlights have shown tetraspanins to play
critical role(s) in immune response-based therapies towards
flaviviruses (7). Although, the immunological mechanism is
essential for the prevention, clearance and control of infection,
bu t c l i n i c a l c h a l l en g e s a r e u sua l l y l i nk ed w i t h
immunopathogenesis and virus-specific immunity (15).
Therefore, there is an urgent demand for development of
course effective and safe vaccine(s) and or novel approaches/
methods requiring improved understanding of the immune
response involved during viral infections. Currently, there are
no therapies/specific drugs or vaccines available for many of the
arthropod-borne flaviviral diseases. Despite substantial progress
in understanding the role of tetraspanins in numerous diseases,
the physiological and therapeutic importance of these family of
proteins in arthropod-borne viral diseases remains largely
unknown. In this review, we provide a broad overview on
the role of tetraspanins in virus-host interactions, virus-
mediated vesicular trafficking, crosstalk with extracellular
vesicle (EVs) and exosome, in the regulation of immune
response mechanism(s) and in their molecular interactions
with RNA. We also discuss the prospects for considering
tetraspanin(s) as novel therapeutic candidates to target
arboviral diseases.
TETRASPANINS ORGANIZATION AND
THEIR ROLE AS REGULATORS OF
VIRUS-HOST INTERACTIONS
Tetraspanins are recognized to play significant role(s) in the
pathology of infectious diseases caused by dengue, corona,
hepatitis and influenza viruses (3). Tetraspanins are an
evolutionarily conserved superfamily of transmembrane
domain-containing proteins with 37 members in Drosophila
melanogaster, and 33 members in humans with characteristic
features and orthologs in other distantly related species, such as
insects and arthropods (16). The evolution and origin of
tetraspanins is largely known but most of these family
member’s functions is less studied or remained unknown due
to the difficulties to understand their subtle functions and/or to
identify their functional redundancies (17). Overall, homology is
highly conserved between isoforms in their primary amino acid
sequence except at the small variable domain located within the
large extracellular loop (LEL). These variations in the LEL region
could explain the functional differences between isoforms, if they
exist within the class of individual members (18). Structural
analysis of different tetraspanins identified a common pattern of
four transmembrane domains in all tetraspanins, but they vary in
number of amino-acid residues, glycosylation pattern and
myristoylation sites (19). Glycosylation and myristoylation sites
in Aedes aegypti Tsp29Fb, human- CD9, CD63, CD81 and
CD151 are predicted using NetNGlyc (http://www.cbs.dtu.dk/
services/NetNGlyc) and PROSITE (ExPASy) and are shown in
(Figure 1A). These small integral membrane proteins with four
transmembrane segments (TM1-4), also have two extracellular
loops of unequal sizes (SEL and LEL), one short intracellular
turn/loop and the N- and C-terminal intracellular tails (Figure
1B) (4). Tetraspanins can be differentiated from other protein
families based on their particular structure of second LEL.
Tetraspanin proteins have 200–300 amino acids, and in
addition they possess characteristic disulfide bonds, a cysteine–
cysteine–glycine (CCG) motif in the large outer loop,
membrane-proximal palmitoylation sites, and at least 2-4
hydrophilic cysteine residues within transmembrane domains
(20, 21). Tetraspanin molecule has also been reported to possess
one or more potential glycosylation, myristoylation, and lipid
modification sites that participates in the regulation of signal
transduction, proteolytic processing, budding, viral entry and
replication, and in viral-host interactions (22). Viruses such as
WNV do not have their own glycosylation machinery (23).
However, it employs the host cell processes to glycosylate its
proteins in order to invade and release from the host cell (23).
Recent studies have shown the crystal structure of CD81 (24) and
CD9 (25), which exposes a reversed cone-like architecture,
suggesting the key mechanistic details for modulation of
tetraspanin function. Tetraspanin enriched micro-domains
(TEMS), also known as tetraspanin web, a distinct class of
membrane domains, share the ability to associate with different
transmembrane receptors (26). TEMs can contain specific
clusters of lipids, transmembrane proteins, membrane
associated proteins, and even signaling molecules (26). They
have been implicated in regulation of tetraspanins function such
as lymphocyte activation, as adhesion receptors involved in
inflammation, pathogen infection and are proposed as
potential candidates for development of novel therapeutic
approaches (26, 27).
Role of Mammalian Tetraspanins in
Virus-Host Interactions
Among all the cell surface proteins, Cluster of Differentiation
(CDs such as CD9, CD63, CD81, CD151, CD82) and
Tetraspanin (Tspan) types that includes Tspan7 and Tspan9
have been reported to be involved in viral infections (1). Studies
investigating different viral structures have shown that specific
tetraspanin proteins are selectively linked with particular virus
and have functions in various stages of infectivity, ranging from
attachment to syncytium formation and release from host cells
(2, 3). Tetraspanins play multifunctional roles in viral entry and
exit process (2). Viruses modulate and use a particular
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tetraspanin molecule as compartmentalizing host entry
factor or as a receptor or co-receptor (1). Coronavirus and
Influenza A-viruses are enveloped RNA viruses (28). TEMS,
specially containing CD9 and CD81 molecules, are the best entry
sites for both these viruses as they are functionally required for
viral fusion (29). Several co-receptors have been identified that
are used by these viruses for glycoprotein-catalyzed process (2,
30). CD9 facilitated condensation of proteases and receptor
permitted rapid and efficient entry of MERS-CoV virus into
host cells (30). CD81-positive endosomes are necessary for the
membrane fusion and entry of influenza virus (29). Coronavirus
membrane fusion is facilitated by the viral spike glycoprotein (S)
and depends on numerous processes such as conformational
changes of the S protein and proteolytic processing (28).
Experiments with mice and cell lines lacking CD9 revealed that
this molecule is critical for entry of human coronavirus strain
229E (28). Likewise, CD81 is involved in HCV entry through
direct interaction with the viral glycoprotein E2 that acts as a
virus receptor (31). Tetraspanins enhance HCV binding by
activating EGFR signaling pathways, which allows tetraspanin/
receptor complex-assembly formation and stimulates CD81-
CLDN1 or CD81-EGFR complex formation (32). Numerous
proteins that contribute in the early steps of HCV infection are
recognized to be located in tetraspanin-interaction network or in
those tight junctions. For example, CD81, a member of
tetraspanin network, is shown as one of the important
components in predicting proteins necessary for early steps in
HCV infection (33). CD81 acts as receptor that directly bind with
envelope glycoproteins E1 and E2, thus, facilitating entry of HCV
and viral binding to host cells (33). Moreover, CD81 interaction
with glycoprotein E2 has been shown to participate in viral
binding and recognition (34). Several of the DNA viruses have
been also shown to modulate the effects of mammalian
tetraspanins. The human herpesvirus (HHV)-6A receptor
CD46 is known to form complexes with the tetraspanin CD9.
Using a genetic approach, knockouts of CD9 in SupT1 cells had
reduced expression of immediate early transcripts but deficiency
for CD46 showed abolished binding and reduced infection in
SupT1 cells. This data indicated a negative role of CD9 for CD46-
independent infection. These studies also suggested that HHV-
6A is strictly dependent on CD46 for entry, although other
proteins, like CD9, may enhance the infection in host cells (35).
Benayas and colleagues showed that the loss of CD81 on herpes
simplex virus (HSV) type-1 infected cells compromised
replication of viral DNA and formation of new infectious
particles (36). Overall, these evidences suggest that viruses use
tetraspanin molecules, proteases, and clusters of receptors for
their entry and trafficking in mammalian host cells.
A B
FIGURE 1 | Tetraspanin structural organization and domain analysis from arthropod and vertebrate host. (A) Schematic diagram showing tetraspanin domain
organization predicted at PROSITE (ExPASy) using primary amino acid sequence of mosquito A. aegypti Tsp29Fb (accession no: AAEL012532-RA), human- CD9
(accession no: NP_001760.1), CD63 (accession no: NP_001771.1), CD81 (accession no: NP_004347.1), and CD151 (accession no: NP_001034579.1).
N-glycosylation sites are predicted using NetNGlycb (http://www.cbs.dtu.dk/services/NetNGlyc) and PROSITE (ExPASy). N-glycosylation sites, which were predicted
in both web tools, are shown. Domain analysis demonstrates presence of conserved tetraspanin domain, 4 transmembrane regions, and variable number of
glycosylation/myristoylation sites, and amino acid sequences. Different regions in tetraspanin proteins are indicated with different colors and labels. (B) Schematic
representation of several characteristic features in tetraspanin protein is shown in the context of its transmembrane architecture. Tetraspanins have four highly
conserved transmembrane domains (TM1-4), two extracellular portions known as small extracellular loop (EC1/SEL) and large extracellular loop (EC2/LEL), one
intracellular loop (trans-passing from domain 2-3), and N- and C-terminal tails. EC2/LEL domain is conserved among several tetraspanins with 2–4 disulphide bonds
(indicated with black lines) formed between cysteine residues in CCG-motif. These residues are binding sites for many interacting proteins and a strong epitope
region for anti-tetraspanin antibodies. Numerous tetraspanins show glycosylation (shown in green lines) in the extracellular loops and palmitoylation sites (shown in
blue line) at the intracellular border of the four transmembrane domains.
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Arthropod Tetraspanins in Virus-Host
Interactions
Arthropods comprises the largest phylum on earth and have
impacted human health significantly throughout the evolutionary
history (37). As disease vectors, arthropods have substantial
interactions with humanity (38). Arthropod vectors play significant
role(s) in the transmission of numerous infectious agents in tropical
and subtropical regions around the globe (39). Arthropods have
established utmost strategies to oblige as successful vectors for
pathogen transmission due to their ability in biting host, taking
blood meal from hosts and allowing microbial replication and
survival in vertebrate host for an extensive period of time (40).
Mosquitoes are the primary medically important vectors that
transmit several of the arboviruses including dengue. Dengue fever
in humans is a painful, devastating mosquito-borne disease caused by
DENV with more than 50 million cases per year, worldwide (41).
DENV exists as four serotypes (DENV1-4) that causes dengue
hemorrhagic fever (DHF), multiple organ failure, and death in
humans (41). The relationship of arthropod tetraspanins with
viruses seems to be predominantly complex. Our study has shown
that arthropod tetraspanin domain containing glycoprotein, Tsp29Fb,
mediates transmission of DENV2/3 from mosquito to mammalian
cells (6). Immunoprecipitation analysis showed a direct co-association
and interaction of Tsp29Fb with DENV2 E-protein, thus indicating
an important function of tetraspanin in facilitating transmission and
replication of DENV2 (6). Silencing of tsp29Fb expression resulted in
a substantial reduction in DENV2 loads in cells and significantly
decreased export of the viral E-protein and RNA genome in
exosomes (6). These findings evidently demonstrated the
importance of arthropod tetraspanins in facilitating DENV2 release,
replication, and transmission (6). Overall, our study suggested that
inhibition of arthropod tetraspanin Tsp29Fb or inhibition of EVs via
GW4869 (a cell permeable, selective inhibitor for neutral
sphingomyelinase (N-SMase)) are both potential therapeutics to
block DENV2/3 and perhaps other mosquito-borne flaviviruses (6).
A mosquito tetraspanin C189 has been found to be upregulated ~4-
fold uponDENV2 infection (42). This tetraspanin was revealed to co-
localize with viral proteins particularly in the plasma membrane of
infected cells and in the intracellular membranes (Figure 2) (42). This
study suggested that due to their involvement in intercellular
adhesion, tetraspanins are presumably essential for the spread of
DENV2 from cell-to-cell (42). In addition, tetraspanin C189 is
crucially involved in cell-to-cell spreading of DENV particles in C6/
36 cells (7). It has been shown that RNAi mediated knockdown of
tetraspanin C189 in mosquito cells reduced virus transmission from
cell-to-cell (7). However, complementation with C189 expression
restored cell-to-cell transmission of DENV in mosquito cells. This
study further observed increased cell-to-cell transmission of DENV at
the site where the donor cell directly interacts with the recipient cell
(7). A recent study has shown that tetraspanin C189 containing
vacuoles mediate cell-to-cell spread of viral RNA within DENV2-
infected C6/36 cells (See Table 1) (43). Magnetic immune isolation
(MI) and sucrose gradient centrifugation showed that DENV2 RNA
is transmitted by C189-VCs from donor to recipient cells. Viral RNA
was only detected in recipient cells in transwell system, indicating that
cell-cell contact is essential for DENV2 intercellular spread (43).
C189-VCs served as carriers for transmission of viral RNA and
virions to neighboring cells after established contact, suggesting
persistent infection in mosquito cells and well-organized
dissemination of DENV2-infection within mosquito vector (43).
Delineating the role of arthropod tetraspanins is an interesting
avenue to investigate the mechanisms of viral transmission.
TETRASPANINS IN VESICULAR
TRAFFICKING AND REGULATION OF EVS/
EXOSOMES UPON VIRAL INFECTION
Tetraspanins and their TEMs received increased attention for
their contribution to exosome biogenesis (Figure 3A), and as
fundamental components that influence the function of
exosomes in vesicular trafficking, internalization, and deviation
from degradation in the proteasome (27, 51). Enrichment of
tetraspanins in EVs/exosomes influences progressive
consideration in unraveling protein-lipid and protein-protein
interactions, intracellular vesicular sorting and membrane
dynamics (27, 51). Exosomes have been defined as greatly
enriched in tetraspanins (52, 53). Besides a set of cytosolic
molecules and common membrane components, the human
exosomes comprises of several tetraspanins including CD151,
CD63, CD9, CD53, CD82, CD37, CD81, and Tspan8 and they
are often used as exosome biomarkers (54). Exosomes are
membrane-bound vesicles, typically of 40–120 nm in diameter
that are released from most cell types such as immunocytes,
blood cells, platelets and endothelial cells (53). Their biogenesis is
constitutively generated by inward budding of early endosomes
(53). Early endosomes then mature into late endosomes before
formation of intraluminal vesicles (ILVs) within large
multivesicular bodies (MVBs) (53–55). Tetraspanin and
tetraspanin-associated proteins that are positioned by TEMs
are arranged into small vesicles during the formation of MVBs
(Figure 3A). Cytoplasmic protein(s) and RNA molecules can be
internalized into MVBs via ceramide-dependent or ESCRTs
pathways (55, 56). The molecules from the MVBs fuses with
the plasma membrane resulting in the release of membrane-
bound vesicles into extracellular space that ultimately becomes
an EVs/exosomes, or the vesicles fuses with the hydrolytic
lysosomes, where these components are subsequently
degraded (55).
Exosomes have been reported to exploit viruses entry route
for cargo delivery (54). Exosomes isolated from HCV-infected
human hepatoma cell lines transmitted virions in the presence of
neutralizing antibodies (45). Binding of tetraspanin CD81 to
HCV established a complex that exploited the fusogenic
capabilities. This HCV-CD81 complex was transferred as cargo
to circulate in hepatocyte cell-derived infectious exosomes (45).
This study indicated a possible role for EVs in securing the
virions and facilitating viral pathogenesis (45). Additionally,
Shrivastava and collegues have shown the role of tetraspanin
CD63 with autophagy proteins in HCV particle secretion and
release within exosomes. They also reported that exosomes carry
infectious viral RNA fragments and tetraspanins play a key role
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in HCV trafficking from the late endosomes to lysosomes (49).
Tetraspanins, CD81 and CD63 are both enriched on exosomes-
derived from HCV-infected cells and CD81 has been shown to
act as receptor for HCV E2 glycoprotein (57). Interferon-
inducible transmembrane proteins (IFITM) have been reported
as effector antiviral molecules that reduce the entry of
flaviviruses, including impact on DENV-mediated cellular
tropism that is independent of receptor expression. Exosomes
carrying IFITM3, enables transmission of antiviral activities
from cell to cell upon DENV infection (58). The molecular
mechanism(s) employed by arthropod-borne flaviviruses to
bypass the blood–brain barrier (BBB) is an unclear and poorly
understood topic. However, it is reasonable to hypothesize that
exosome-mediated crossing of the BBB might be a crucial
mechanism for flavivirus neuropathogenesis (59). Our current
studies are highly focused on undertaking these ideas to reveal
these mechanisms. Recent study revealed that genome of ZIKV
could be identified in the fetal brain and the amniotic fluid,
which endorses that exosome pathways contribute in the viral
transfer across the placental barrier (60). Likewise, in in vitro
conditions, neuronal exosomes aid in ZIKV transmission
between murine cortical neurons in embryonic brains (61). It
was reported that neuronal exosomes contain both ZIKV
RNA and proteins that modulate infection of this virus to
naïve recipient cells (61). Furthermore, assays performed
with neutralizing antibodies and RNaseA-treatments revealed
FIGURE 2 | Proposed model for the role of tetraspanins in viral interactions. Mosquito tetraspanin Tsp29Fb is involved in DENV2/3 transmission from arthropod to
mammalian cells, and Tsp C189 play a key role in cell-to-cell spreading of viral particles (indicated as step 1). Tetraspanin Tsp29Fb directly interacts with viral
E-protein and perhaps might act as co-receptor for viral entry (denoted as step 2), and in specific serve as a receptor in case of arbovirus entry during clathrin-
dependent receptor-mediated endocytosis (shown as step 3) and/or for internalization of viral particles by endocytosis (indicated as step 4). Tetraspanin proteins
trigger the fusion and viral uncoating process (represented as step 5). Tetraspanins in association with several other host proteins are implicated in replication
(denoted as step 6) and in translation process (shown as step 7). Tetraspanins participates to enable the delivery of viral genomes into the nucleus for successful
infection and assembly processes (noted as steps 8). Tetraspanin contribution is highlighted in budding and assembly formation (noted as step 9) and in membrane
fusion events can be exploited for viral exit from cells via direct release of secretory vesicles such as exosomes (represented as step 10). The step numbers have
been classified into two color codes (light blue or dark gray). Role of arthropod tetraspanin in entry/exit of flaviviruses is proposed research and indicated in light blue
color, whereas the published data is represented as dark gray circles.
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that ZIKV proteins/RNA were present inside of the exosomes
(61). Exosomes serve as functional carriers of mRNAs and
miRNAs between cells, suggesting their role in cell–cell
communication (62).
Exosomes secreted from DENV-infected cells mediate safe
viral transmission, thereby, enabling virus protection from anti-
dengue neutralizing antibodies (59, 63). Our recent reports
provided evidence for the first time to suggests that flaviviruses
use exosomes for their transmission from arthropod to
vertebrate cells through interaction(s) with arthropod
exosome-enriched proteins (6, 53, 64). A molecular and
cellular study reported a novel role for Tsp29Fb, an increased
tetraspanin in arthropod exosomes, in mosquito-dengue virus
interactions (6). Another study reported that exosomes-derived
from DENV-infected Aedes albopictus C6/36 cells contained a
protein that showed cross-reactivity to an antibody against the
human CD9 (65). Exosomes released from DENV-infected C6/
36 cells were bigger in size than the ones secreted from
uninfected cells (65). These exosomes were able to infect naïve
C6/36 cells, indicating that exosomes play a significant function
in DENV dissemination (65). It was noted that arthropod
exosomes play key roles in transmission of flaviviral RNA and
proteins to naïve human cells (64). This study not only provided
evidence that transmission of LGTV is facilitated by arthropod-
derived exosomes but also that LGTV uses exosomes for
dissemination to the vertebrate host cells (64). Both negative
and positive LGTV RNA strands, viral envelope (E) and non-
structural (NS1) proteins, and perhaps polyprotein were
identified in exosomes-derived from tick and murine host cells
(64). Treatment with GW4869, not only reduced exosome
production and release but also affected LGTV loads in
exosomes-derived from tick and neuronal cells (64). Another
recent study revealed that LGTV-mediated suppression of
IsSMase plays a key role in exosome biogenesis and in
membrane-associated viral replication, which provided new
insights in the involvement of vector defense mechanism(s)
and antiviral pathways against tick-borne viral infections (66).
Our novel discovery showing the presence of in vivo exosomes in
tick saliva and salivary glands revealed a role for these arthropod
EVs in regulating the immune response at the tick-human skin
interface via IL-8 and CXCL12 (67). Treatment of human skin
keratinocytes (HaCaT cells) with tick saliva/salivary gland-
derived exosomes induced IL-8 and reduced CXCL12
chemokine that lead to dramatic delay in cell migration,
wound healing and repair process during the scratch assay
(67). Exogenous treatment of CXCL12 (2 µg of purified
protein) completely restored these delays and indeed enhanced
the repair process suggesting a skin barrier protection role for
this chemokine at the tick bite site (67). Overall, this study
showed that tick salivary exosomes secreted in saliva regulates
host immune response at the tick bite site to allow continuous
blood flow and persistent feeding. We believe that tick or
mosquito encoded antigens would be ideal candidates for the





The tetraspanins and their associated-proteins propose possible
models for molecular interactions in modulation of the immune
system (68). Tetraspanins are expressed on all cells of immune
system, which provides a scaffold that enables the temporal and
spatial engagement of their associated proteins (1, 68, 69).
Tetraspanin are expressed on leukocyte subsets such as
macrophages, monocytes, T and B lymphocytes, dendritic cells,
granulocytes and natural killer cells (68–70). These proteins bind
directly or indirectly with different molecules -for example, B-cell
receptors, T-cell receptors, a4b1 and a6b1 integrins, major
histocompatibility complex (MHC) class I, MHC class II etc.,
that play significant role(s) in the modulation of different
immune cells (69, 71). Enrichment of tetraspanins on
exosomal membranes suggests a novel mode in intercellular
TABLE 1 | Tetraspanin functions in various cellular processes.
Tetraspanin Pathogen Involvement in biological function/process Reference
Arthropod tetraspanins
Tsp29Fb DENV2 Transmission of DENV2/3 from arthropods to mammalian cells (6)
Tetraspanin C189 DENV2 Cell-to-cell spreading of DENV2 (7, 42)
DENV2 C189-containg vacuoles participate in transmission of viral RNA and virions to neighboring cells (43)
Host tetraspanin
CD81 HCV Direct interaction with the viral glycoprotein E2 and acts as a virus receptor (31, 33)
HCV Participate in viral trafficking (34)
HCV CD81 partner EWI-2 inhibit viral entry (44)
HCV Role for extracellular vesicles in securing the virions (45)
Modulate B cell receptor-mediated signaling (46)
Ag processing and presentation (47)
IAV Viral uncoating and budding (29)
CD63 EBV Involved in intracellular signaling (48)
HCV Viral trafficking from late endosomes to lysosomes (49)
CD9 MERS-CoV Viral entry and fusion (30)
CD151 TEM assembly (50)
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communication, which has significant function in numerous
cellular processes, including antigen presentation, signal
transduction, and modulation of immune responses (1, 68, 69).
Evidences on the role of CD81 in immune cells has now begun to
deliver concrete links between particular function and a specific
molecule (70). These include roles associated with CD4 in T cells,
integrins in B cells and T cells, CD81 with CD19 and MHC class
II molecules in B cells (Figure 3B) (69). Crosslinking of
tetraspanins CD9 and CD81 antibodies modulated T cells,
suggesting their function as positive effectors (72).
Furthermore, CD151, CD37, CD81, and TSPAN32 down
modulated T-cell triggering in response to in vitro stimulation
by sequestering key molecules into TEMs (73). CD81 also
contribute to efficient association and molecular organization
between the B cell receptor and its partners (72).
Studies have shown the involvement of tetraspanin
connections with MHC class I and class II, including MHC’s
on T cells (CD82), and antigen-presenting cells (CD9, CD81) as
both of them distribute into the immune synapses (Figure 3C)
(74). Tetraspanin CD151, TSPAN32, and CD63 have been
shown to be associated for normal platelet functions. Platelets
from tetraspanin CD63-null mice showed delayed clot retraction,
impaired spreading on fibrinogen and defective platelet
aggregation (75). CD81 is the most studied tetraspanin on
immune-cells, and its significance has now been recognized in
different functions including Ag-induced B cell activation, as a
FIGURE 3 | Role of tetraspanins in exosome biogenesis and modulation of immune signaling. (A) Role of tetraspanins in exosome biogenesis is shown. The early
endosome formation is the first step in vesicle uptake and recycling. Development of early multivesicular bodies (MVBs, shown in green complex) is dependent on
sorting of cytosolic proteins, clathrin-coated membranes, RNA molecules, tetraspanin-enriched domains (TEMs), and lipid rafts. The sorting and packaging of several
other molecules into exosomes cannot be ruled out and has not been shown for simplicity. Some mature multivesicular bodies (MVBs) fuse with the hydrolytic
lysosome, where the vesicular cargo is subsequently degraded. The membranes of late MVBs fuses with the plasma membrane resulting in the release of exosomes/
EVs into the extracellular environment. (B) Tetraspanins role in miRNA modulation is shown. Tetraspanins directly or indirectly interacts with different signaling
molecules and receptor(s) at the membranes/lipid rafts, and organize into the specialized tetraspanin-enriched micro-domains (TEMs) that might play significant role
during exosome cargo sorting (miRNAs, RNA, and proteins) from viral-infected cells to recipient cell. (C) Tetraspanin involvement in signaling pathway is shown.
Exosomes are potential in the context of modulation of an immune response through their ability to present MHC–peptide complexes to specific cells, resulting in
activation of T cells and antigen presentation cells.
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receptor for HCV entry, T-cell activation, Ag processing and
presentation (47). Moreover, CD81-enriched microdomains has
been shown to organize Nano-clusters to modulate B cell
receptor-mediated signaling (46). Tetraspanin CD63 functions
as a bridge in endosomal and autophagic processes to modulate
the major viral oncoprotein. It affects the latent membrane
protein 1 (LMP1) levels for exosomal secretion and allows
intracellular signaling of Epstein-Barr Virus (EBV) within
infected cells (48). It has been demonstrated that CD63 is
essential for efficiently packaging of LMP1 into exosomes/EVs
(48). During EBV infection, CD63 act as a negative regulator and
directly opposes intracellular signaling activation downstream of
LMP1 including mTOR cascade to deactivate host cell autophagy
and to facilitate cell growth and proliferation (48). Interactions of
tetraspanins with pattern-recognition receptors (PRRs) have
provided novel insights into the organization of Ag receptors
in modulation of downstream signaling pathways (76). The C-
type Lectins receptors (LARs) are promising candidates for
recognizing pathogen associated molecular patterns (PAMPs),
and direct targeting of these LARs is commonly used as effective
strategy to treat flaviviral infections (77). Tetraspanins
collaborates with C-type Lectins to enhance viral attachment to
cells and thus facilitates flavivirus infection (78). Collectively,
these evidences highlight the new insights in the involvement of
tetraspanins to modulate immune responses.
PUTATIVE ROLES FOR NONCODING
RNAs IN MODULATION OF
TETRASPANINS
Noncoding RNAs (ncRNAs) molecules play a variety of
functions such as siRNAs has been involved in antiviral
defenses, miRNAs and piRNAs controls transposons and
regulation of gene expression, and lncRNAs mainly
implicated in modulation of immune response mechanism of
flaviviruses (79). Exosomes generated from HCV-infected cells
induces the myeloid-derived suppressor cells through direct
targeting of the miR-124-mediated signaling pathway (57). The
miRNAs-125b and -146a targeting tetraspanin-12 enhances the
NF-kB activity, suggesting that these miRNAs have tremendous
potential to modulate innate immune response in brain cells
(80). Recent study has shown the important role of exosomes as
vehicles for miRNAs (including miR-223, let-7a, miR-150,
miR-1229, miR-23a, miR-1246, and miR-21) transport to
recipient cells (81). Studies on miRNAs targeting exosomal
tetraspanin such as CD151, CD9 and CD81, suggests that
exosomes are present in all bodily fluids, and that exosomes
serves as diagnostic markers and therapeutic delivery vehicles
for infectious diseases (82).
Flaviviral infections accumulate different patterns of ncRNAs
relevant in immune evasion and viral pathogenesis that
differently regulate viral fitness in host. A key characteristic
feature of this advancement is recognition of the importance of
ncRNAs interaction(s) with RNA-binding proteins (83). RNA-
binding proteins has been known to play key roles in miRNAs
mediated gene regulation, regulation of miRNA biogenesis, and
in recognition and modulation of miRNA targets (83). A recent
study has shown to increase incorporation of miRNAs in
exosomes that regulate gene expression involved in pro-
inflammatory and antiviral responses upon WNV infection
(84). Next-generation sequencing approach has identified a
potential role of Ixodes scapularis tick miRNAs in viral
replication including POWV (85), and LGTV (86). Our group
has also recently shown that repression of tick miRNA facilitates
rickettsial pathogen survival and transmission to the vertebrate
host (87). Currently, microRNA-targeting has been developed as
an active strategy for pathogenicity and for the selective control
of tissue-tropism of RNA viruses (88). In addition, small RNA
profiling reveals differential expression of host piRNAs and
miRNAs that modulates DENV2 replication in A. aegypti
mosquito cells (89). A study has reported differential
expression of arthropod miRNAs (that are highly conserved in
vertebrates) upon infection of mosquitoes with flaviviruses such
as ZIKV, DENV and WNV (90). These findings indicate an
important role for miRNAs in targeting tetraspanins that could
serve as potential therapeutic targets.
Viruses have established numerous strategies to enhance the
efficacy of replication and to encounter antiviral immune
system. Among these strategies adopted by viruses,
lncRNA molecules are involved in viral-vector interaction(s)
and have greater impact on viral biology (91). Arthropod-borne
flaviviruses produce sub-genomic flavivirus RNAs (also known
as sfRNAs that are ∼300-500 bases in length) or Xrn1–resistant
RNAs (xrRNAs) (92). Both lncRNAs have a mutual molecular
mechanism for their generation, but they have differences in
various functions implicated in the flavivirus life cycle (93).
Besides this, sfRNA play a significant role in RNAi-mediated
pathway that impact in modulating antiviral immune response
(94). Another study has shown that substitutions in the NS5
(non-structural 5) protein increases the delivery of sfRNA to
new susceptible cells in order to inhibit type I IFN induction,
which might be used as an effective strategy to control DENV
replication (95). Silencing of tetraspanins (CD151, CD81, CD63
and CD9) expression in A549 cells resulted in significantly
lower sfRNA copies in exosomes, indicating that sfRNA is
packaged in infectious particles containing DENV envelope
(E) protein or in virions (95). CD63 antibodies were used to
deplete exosomes to determine whether sfRNA is packaged
exclusively in virions or in exosomes. Although, exosomes
could be removed from cell culture supernatant, but they
could not be fully depleted, and sfRNA:gRNA ratios
remained higher in culture supernatant, indicating that
sfRNA is securely contained in DENV E-protein containing
particles including exosomes or in virions (95). Several
evidences have exposed the involvement of sfRNA in
targeting host-derived proteins upon flavivirus infection (96,
97). Genome wide profiling of lncRNA expression identified
MAGED1, STAT1, and IL12A genes that might play a key role
as biomarkers for designing new strategies to prevent DHF
(91). Transcriptomic analysis of lncRNAs profile of A.
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aegypti cells identified a set of differentially expressed immune-
related genes implicated in IMD and MAPK signaling pathway
responsive to DENV infection (98). Collectively, these
observations highlight the significance of ncRNA in viral
replication, transmission, and immunity, but further research
enhancement on this topic is needed to fully reveal the
mechanism(s). Future studies should focus not only to
understand the involvement of ncRNAs in regulation of the
vertebrate host immune response but also should emphasize on




DENV, ZIKV, and WNV infect millions of people worldwide.
Tetraspanins could be considered as strong therapeutic target(s)
due to their role in viral interactions. Strategies such as RNA
interference (RNAi) and antibody-mediated blocking of
tetraspanin proteins function could be developed as ideal
approach to prevent viral infections. Treatment with antiviral
drugs such as viral-cell receptor interaction inhibitors,
interferon’s, and viral enzyme inhibitors could lead into
significant reduction in the viral loads but these may not
completely eradicate viruses (99). Additional difficulties
associated with these approaches include low efficacy owing to
viral genotype specificity, toxicity and side effects, development
of viral resistance, patient immune variability and high cost (99).
Progress to develop novel vaccines for flaviviruses has been
hindered by poor capacity and potential pathogenicity to elicit
protective immune responses (99). Tetraspanins can be broadly
classified into two groups based on their function of direct
interactions with viral-expressed proteins, and their
dependence on TEMs that effects host-cell functions.
Tetraspanin–pathogen direct interactions reflect a necessity of
the invading pathogen to interact with TEMs (1). Numerous
viruses are assumed to have established complex interactions to
‘highjack’ or exploit lipid rafts (3). TEMs may provide many
viruses with ‘gateways’ to enter and leave host cells without any
interference (1, 3). Models where tetraspanins directly interact
with viral proteins provide better understanding for the
development of therapeutic strategies. These strategies should
focus to specifically block viral replication, prevent mutations in
the viral genome and cause no adverse effects to the host (99).
Advance use of such approaches is of great concern and these
methods are becoming progressively more prominent with the
failure of traditional methodologies of vaccination that were used
to control and treat viral infections (99). Also, the appearance of
new strains due to mutations in viral genome in human
populations set limits for these traditional methodologies
(100). The best characterized example of tetraspanin specific
direct interaction is CD81 with HCV E2 glycoprotein that
implies the small-molecule inhibitors targeting this tetraspanin
could prove valuable treatment for HCV infection (101). A study
demonstrated that CD81’s large extracellular loop (LEL) had no
effect on infection by serum-derived HCV, whereas CD81 down
regulation by siRNA or anti-CD81 antibodies markedly inhibited
the entry process of HCV (102). Tetraspanin CD81 plays a
critical role in HCV infection in vitro, and anti-CD81 antibody
administration have been shown to exhibit a protective role in
vivo (103). The immunoglobulin superfamily member IgSF8
(also known as EWI-2) directly binds to tetraspanin CD81.
Therefore, inhibiting the interaction between HCV E2
glycoprotein and CD81, will result in the blockade of viral
entry (44).
The palmitoylation of tetraspanin CD9 and CD151 plays a
significant role in TEM assembly that could possibly suggests
novel target for microbial infections (50). It has been shown
that palmitoylation of CD9 plays a role in mediating DHHC2
suppression in A431 cells to affect cell performance (50).
CD151 palmitoylation has been reported to play significant
function in assembly of the large network of cell surface
tetraspanin-protein interactions, distribution in tetra-CD151
showed markedly diminished stability during biosynthesis.
Disruption of tetraspanin domain through palmitoylation
dynamics may therefore represent a candidate therapeutic
strategy to combat viral infections (104). The siRNA-
mediated knockdown of tetraspanin CD151 or antibody-
mediated blocking of CD81 was shown to reduce virus
entry/internalization. This data suggested that CD81 and
CD151 could possibly be targets for blocking HCV
infection (105).
Genome wide RNAi-based screens are used for identification
of host proteins that play a significant role in advancement of
clinically important data (106). A set of host proteins involved in
the regulation of cellular pathways for many aspects of WNV
infection have been identified (107). Using the same RNAi
approach used for WNV, it has been revealed that
approximately half of the factors are unknown (that may
contain mosquito TSPs) and one third of the known factors
were involved in the replication of DENV2 (108). Interestingly,
silencing of gene expression of proteins that were up-regulated
upon WNV infection also affected DENV2 infection,
demonstrating that these proteins play a vital role in restriction
of flaviviruses growth (108). Among the differentially expressed
proteins, 116 genes were considered important as insect host
factors for DENV2 propagation, vesicular trafficking (like
VATPases and accessory proteins), and among which 82 of the
host factors had identifiable human homologs (108). The siRNAs
targeting human homologs revealed that 42 of these proteins
considered as positive factors that affected DENV2 growth,
showed notable conservation of required factors between
insect, vector and the mammalian hosts (108). In addition,
antibodies against specific tetraspanin’s that are exogenously
internalized could be delivered via recombinant exosomes
(109). Arthropod CD63 ortholog Tsp29Fb has been recently
described as a target for this type of therapies in viral infection. In
our previous study, we revealed that arthropod EV-enriched
tetraspanin domain-containing glycoprotein, Tsp29Fb play an
important role in transmission of DENV2 (6). Identification of
Ahmed et al. Role of Tetraspanins in Viral Interactions
Frontiers in Immunology | www.frontiersin.org April 2021 | Volume 12 | Article 6305719
this tetraspanin in vector host, has conceivably suggested
Tsp29Fb as potential biomarker for future therapeutic
approaches to combat arthropod-borne viruses. Recent
advances in genetic engineering technologies have made it
possible to create mosquitoes that block key interactions
between the mosquitoes and pathogens, this includes
physically blocking the key interactions required for the
pathogen development. It has been shown that genetically
engineered A. aegypti mosquitoes efficiently expressed a
DENV-targeting single-chain variable fragment (scFv) derived
from a previously characterized broadly neutralizing human
antibody, which blocked the infection and transmission in
these mosquitoes (110). Taken together, all these studies
provide evidence that targeting tetraspanins may provide novel
strategies to inhibit critical processes, and aid in the development
of potential therapeutic targets to treat and/or control several of
the vector-borne flaviviral infections.
CONCLUSION AND FUTURE
PERSPECTIVES
Arthropod-borne viruses are important pathogens that
cause devastating diseases in humans. Development of
transmission-blocking vaccines targeting vector or pathogen
molecules is an effective strategy to eliminate and control
arthropod vectors and to prevent arthropod-borne infections
(111). Although, continuing efforts to improve and advance
traditional approaches to fight against vector-borne diseases
have not been ignored, however, novel strategies are required
immediately. Recent evidence suggests that pathogens uses or
associates with tetraspanins as a mean for entry, replication,
and exit from the host cell. Our studies have shown that
tetraspanin domain containing glycoprotein Tsp29Fb, an
ortholog of human CD63 mediates transmission of DENV2/
3 from arthropod to mammalian cells (6). Tetraspanin might
play significant role(s) as receptors, as mediators in the
compartmentalization of host entry factors at the membrane,
as facilitators in fusion and cell-to-cell spreading of viral
particles, and as activators of EGFR signaling pathways.
Exosomal tetraspanin CD9, CD63 and CD81 are important
molecules that are involved in many functions including
vesicular trafficking, internalization of antigens and in
transmission of human pathogens including DENV, WNV,
ZIKV, LGTV and HCV. Tetraspanins are expressed on all
immune cells providing a scaffold that enables the temporal
and spatial engagement of their associated proteins.
Tetraspanin proteins might bind directly or indirectly with
different molecules such as, B-cell or T-cell receptors, a4b1
and a6b1 integrins, MHC classes I and II components in
order to modulate the activity of immune cells during
viral infections.
Tetraspanins also play a key role in the regulation of different
cellular processes. RNAi-mediated repression of tetraspanin gene
expression or antibody-mediated blocking of tetraspanins function
could be employed as effective antiviral strategies to control
infections. One of the other thoughts is will it be helpful to make
knockout mosquitoes for different arthropod TSPs, and will it be
feasible to free knockout or genetically modified mosquitoes lacking
TSPs in the field. However, it is important to first delineate if these
knockout mosquitoes will survive in nature without TSPs. Genetics
and transgenetic are quite strong in mosquitoes when compared to
ticks, however, there could be several challenges to make knockout
mosquitoes. RNAi-mediated silencing of mosquito Tsp29Fb (a
human ortholog of CD63) significantly reduced DENV2 loads in
both mosquitoes and the infectious EVs derived from these cells.
We did not observe anymorphological or viability issues with theA.
aegypti mosquito cells. This data indicates the possibility of
generating feasible knockouts for Tsp29Fb and perhaps other
TSPs in mosquitoes. Our immediate future line of research is
centered on these important thoughts. Due to their important
roles in several processes as discussed in this review article,
therapeutic strategies based on targeting tetraspanins would
provide better success for treating/preventing vector-borne
diseases. Although, involvement of tetraspanin superfamily has
been studied in different aspects, limited information is available
for these molecules compared to the studies that reported on other
transmembrane domain containing proteins, such as GPCRs and
integrins. There are numerous questions that need to be answered
with regard to the involvement of arthropod tetraspanin(s) to
understand their full potential for therapeutics chassis a) how do
arthropod tetraspanin(s) can be used as therapeutic targets for
vaccine or antiviral drugs? b) How do ncRNAs interfere with
tetraspanins in the modulation of immune responses and
respective cellular mechanisms? c) How do three-dimensional
structures of different tetraspanins appear? d) Could arthropod
tetraspanins affect immune responses to flaviviruses and other
microbes? e) What other putative viral co-receptors participate
with arthropod tetraspanins to modulate the viral entry and
release? f) Is it feasible to generate genetically modified vector
such as mosquitoes or ticks lacking tetraspanin? In summary,
detailed characterization of arthropod tetraspanin(s) will not only
facilitate our understanding of pathogenicity of flaviviruses but also
will lead to the development of novel effective therapeutic tools such
as antiviral drugs and vaccines to combat vector-borne diseases.
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